期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血小板糖蛋白Ⅱb/Ⅲa受体拮抗药与冠心病-急性心肌梗死

下载PDF
导出
摘要 随着生活水平的提高、生活模式的改善、工作节奏的加快、人类平均寿命的延长等多种因素的作用,冠心病的患病人数、发病率逐年增加,给人类的生活带来了重大影响,故而冠心病的治疗至关重要。
作者 张一达 马静 王凯华 金湘辉 王珠秀
机构地区 承德医学院附属医院 承德医学院附属医院承钢分院
出处 《承德医学院学报》 2012年第2期191-193,共3页 Journal of Chengde Medical University
关键词 冠心病 急性心肌梗死 血小板膜糖蛋白Ⅱb/Ⅲa受体拮抗剂
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献13

  • 1THE CURE INVESTIGATORS.Effects of clopidogrelin addition to aspirin in patients with acute coronarysyndrome without ST-segment elevation[J].N Engl JMed,2001,345(7):494-502.
  • 2Lewis BS,Mehta SR,Fox KA,et al.Benefit of clopidogrelaccording to timing of percutaneous coronary intervention inpatients with acute coronary syndromes:further results fromthe Clopidogrel in Unstable angina to prevent RecurrentEvents(CURE)study[J].Am Heart J,2005,150(6):1177-1184.
  • 3Fox KA,Mehta SR,Peters R,et al.Benefits and risks of thecombination of clopidogrel and aspirin in patients undergoingsurgical revascularization for non-ST-elevation acute coronarysyndrome:the Clopidogrel in Unstable angina to preventRecurrent ischemic Events(CURE)trial[J].Circulation,2004,110(10):1202-1208.
  • 4Fernandez A,Aboodi MS,Milewski K,et al.Comparison ofadverse cardiovascular events and bleeding complications ofloading dose of clopidogrel 300 mg versus 600 mg in stablepatients undergoing elective percutaneous intervention(fromthe CADICE study)[J].Am J Cardiol,2011,107(1):6-9.
  • 5Eriksson P.Long-term clopidogrel therapy after percutaneouscoronary intervention in PCI-CURE and CREDO:the“Emperor’s New Clothes”revisited[J].Eur Heart J,2004,25(9):720-722.
  • 6Cho L,Bhatt DL,Wolski K,et al.Effect of smoking statusand abciximab use on outcome after percutaneous coronaryrevascularization:Pooled analysis from EPIC,EPILOG,andEPISTENT[J].Am Heart J,2001,141(4):599-602.
  • 7Lincoff AM,LeNarz LA,Despotis GJ,et al.Abciximab andbleeding during coronary surgery:results from the EPILOG andEPISTENT trials[J].Ann Thorac Surg,2000,70(2):516-526.
  • 8The CAPTURE investgators.Randomized placebocontrolledtrial of abciximab before and during coronary interventionin refractory unstable angina:the CAPTURE study[J].Lancet,1997,349(9036):1429-1435.
  • 9Lincoff AM,Tcheng JE,Califf RM,et al.Sustained suppressionof ischemic complications of coronary intervention by plateletGP IIb/IIIa blockade with abciximab:one-year outcome in the EPILOG trial[J].Circulation,1999,99(15):1951-1958.
  • 10Schulz S,Mehilli J,Neumann FJ,et al.ISAR-REACT 3A:a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention[J].Eur Heart J,2010,31(20):2482-2491.
承德医学院学报
2012年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部